 |
| Modules | |
| Google | |
|
These ads help pay for the upkeep of our site. They are automatically served by Google and are not affiliated with This is MS. | |
| Languages | |
|
Select Interface Language:
| |
| Who's Online | |
There are currently, 184 guest(s) and 9 member(s) that are online.
You are Anonymous user. You can register for free by clicking here | |
| Next Step | |
| Donations | |
|
To remain unbiased, This is MS does not accept corporate sponsorships. Therefore, we must rely on our users to help support us. Please donate to our upkeep if you have the means. Thank you! | |
| |
 | PML Seen with Rituxan for Lupus |
 Our old nemesis, progressive multifocal leukoencephalopathy, or PML, has reared its ugly head yet again, this time in association with another of Biogen's drugs, Rituxan.
PML, if you recall, was implicated in the multiple deaths associated with Tysabri last year, leading to its temporary suspension. After much analysis and an unprecedented patient board hearing by the FDA...
Story continues, please click 'read more'
Advertisement
...Tysabri has been brought back but only under intense scrutiny-- designed to detect PML at its earliest stages until the cause is better understood.
Rituxan destroys the body's B-cells, a component of the immune system, with the idea that they will regenerate free of their previous issues, be it cancer or sponsoring another autoimmune condition like rheumatoid arthritis. In the two recent cases, Rituxan was being used to treat Lupus, another autoimmune condition, on an off-label basis. Today Rituxan is only approved to treat Rheumatoid Arthritis and Non-Hodgkins Lymphoma, but it is in trials for lupus as well as cancer and Multiple Sclerosis (Phase II/III for PPMS and Phase II for RRMS).
Note that in its indication for Lymphoma, there have already been *23* cases of PML, and the labeling includes a warning for it. Biogen commented that PML has been seen in cancer and lupus patients who are not being treated with Rituxan as well. Many in the MS community came away from the Tysabri-Avonex-PML debacle thinking that PML, aside from severely immuno-compromised HIV patients, was first seen in our community. Instead, it comes to light over time that this disease is seen in many patient populations where the background of hte disease process is abnormal regulation of the immune system, perhaps in combination with powerful immuno-modulator drugs.
|
|
|
|
| |
| Login | |
|
Don't have an account yet? You can create one. As a registered user you have some advantages like theme manager, comments configuration and post comments with your name. | |
| Related Links | |
| Article Rating | |
Average Score: 4.53
Votes: 13
| |
| Options | |
|
Re: PML Seen with Rituxan for Lupus (Score: 1)
by msladyinca on Thursday, December 28 @ 16:18:13 EST
(User Info | Send a Message) | | Thanks Aaron, however your readers should be aware: There were NOT "multiple deaths" associated with Tysabri last year....PML was found in 1 in a Crohn's trial patient with a severely compromised immune system, and in 1 in a trial patient that received combination therapy WITH Avonex, who, upon autopsy revealed did NOT have MS. Therefore, not one single confirmed MS patient with a non-compromised immune system that received Tysabri as a monotherapy in either the trials (3,000 pts) or in the general population from 11/04 to the end of 2/05 (5,000 pts) ever developed PML OR died...ZERO, i.e., a risk factor of 0:8000. Lauren |
|
|
|
|
